We Are Part of The Sartorius Stedim Biotech Group, a Global Provider of Laboratory and Pharmaceutical Equipment.

Based near Cambridge UK, we specialize in the design and manufacture of automated cell culture and fermentation systems for the bio-pharma, regenerative medicine and industrial biotechnology sectors, focusing on:

  • Bioprocess Development
  • GMP Manufacture of Biologics
  • Cell Therapy and Stem Cell Research
  • Discovery Research




Sartorius introduces BioPAT® Spectro to enable Raman spectroscopy capability and QbD with its ambr® and BIOSTAT STR® platforms More >>

New ambr® 250 Modular Bioreactor Vessel Launched for Cell and Gene Therapy Applications More >>

Sartorius Stedim Biotech launches new ambr(R) 15 cell culture microbioreactor system More >>

Sartorius Stedim Biotech Introduces Mini Microcarrier Bioreactor for Culturing Adherent Cells More >>

Sartorius Stedim Biotech launches new ambr® 250 high throughput bioreactor system for perfusion culture More >>

Engineer Wins Second Cambridge Regional College Award More >>

Ingenza invests in ambr 250 modular technology for fast fermentation development More >>

Local Firms Invited to Join Exciting STEM Initiative - Helping Children Understand the Appliance of Science More >>

Sartorius Stedim Biotech launches ambr® 15 bioreactor system with Nova BioProfile® FLEX2 integration More >>

Sartorius Stedim Biotech Partners with Nova Biomedical - Firms combine ambr® technology with the BioProfile® FLEX2 More >>

Award-Winning Engineering Apprenticeship Scheme at Royston site now open for applications More >>

New Webinar on Implementing the ambr® 250 Modular Benchtop Bioreactor - With A Case Study From Cobra Biologics More >>

New Webinar on Developing Process Workflows for Rapid Scale-Up - With a Case Study from WuXi Biologics More >>

Sartorius Stedim Biotech launches innovative ambr® 250 modular bioreactor system More >>

WuXi Biologics and Sartorius Stedim Biotech Open Joint R&D Biologics Laboratory in Shanghai More >>

New Poster on High Density Fed-Batch Microbial Screening Using Micro Bioreactors More >>

Sartorius Royston actively recruiting for a variety of roles within this growing business More >>

Science and Technology Workshops Launched for Primary & Middle Schools More >>

Sartorius Royston wins STEM Apprenticeship Employer of the Year and Overall Employer of the Year Awards More >>

Ginkgo Bioworks chooses ambr 250 Systems to enable High Throughput Process Development of Engineered Microbes More >>

New paper from WuXi AppTec on Shortening Timelines for Bioprocessing of Protein-based Therapeutics More >>

New Webinar - ambr15 microbioreactor as a sedimentation-perfusion model More >>

New SelecT Mk5 Automated Cell Culture System Launched on Booth 1223 at SLAS More >>

New ambr 15 fermentation system for enhanced microbial strain screening More >>

RAFT 3D cell culture system to be exclusively distributed by Lonza Bioscience More >>

ReNeuron to use Cellmate Automated Cell Culture for Stem Cell-based Stroke Therapy More >>

New webinar: Using ambr 250 for effective scale-up to cGMP manufacture of biotherapeutics More >>

ambr 15 and ambr 250 bioreactor systems enhanced with Design of Experiments (DoE) software More >>


ambr 15 cell culture Generation 2
Focus on: On-Demand Webinar - Introducing NEW Ambr® 15 Cell Culture
Generation 2 Launch Webinar.

The newly launched Generation 2 system is the successor to the original Ambr® 15 Cell Culture design and provides increased flexibility, enhanced performance and extended capability to support more applications.

In this webinar Alison Rees-Manley, Ambr® 15 Product Manager, and Dr. Sinyee Yau-Rose, Ambr® Software Applications Product Manager, gives an overview of the new Ambr 15 Cell Culture Generation 2 system and its supporting Ambr® clone selection powered by Umetrics® software application.

Request access to this webinar to receive the recording and listen on-demand.



View our Latest Job Opportunities